期刊文献+

气相色谱-质谱改良法测定血浆舒芬太尼浓度的建立 被引量:3

Establishment of modified gas chromatography-mass spectrometry for determination of plasma sufentanil concentrations
原文传递
导出
摘要 目的 对气相色谱-质谱法(GC-MS法)测定血浆舒芬太尼浓度进行改良.方法 以芬太尼为内标,血浆标本经乙酸乙酯-石油醚萃取,采用色谱柱HP-5MS,初始温度为130℃,最终温度为320℃,进样口温度为290℃,接口温度为300℃.载气为高纯氦气(纯度99.999%),恒流流速为1ml/min,进样方式为不分流进样,进样体积为1μl.质谱条件中选用EI源,离子源温度230℃,四级杆温度150℃,电子轰击能量70 eV,倍增电压2112 V,选择性离子监测模式.溶剂延迟为7 min,分组进行采集,根据舒芬太尼及芬太尼的离子特征曲线于8.20~8.40 min采集舒芬太尼的特征离子,7.60~7.80 min采集芬太尼特征离子.结果 标准曲线提示舒芬太尼浓度在0.02~ 10.00 ng/ml范围内与色谱条件下的峰面积比线性关系良好,其方程:y=0.1625X+ 0.0316,R2=0.9987,萃取回收率>80%,日内和日间精密度均小于8%,最低检测浓度为0.02 ng/ml.结论 GC-MS改良法测定舒芬太尼血药浓度,不仅测定敏感、准确,而且操作简化,更适用于舒芬太尼的药理学研究. Objective To modify gas chromatography-mass spectrometry (GC-MS) for determination of plasma sufentanil concentrations.Methods Fentanyl was used as the internal standard.The plasma samples were extracted with ethyl acetate and petroleum ether.An HP-5MS capillary column was used.The initial temperature of the column was set at 130 ℃,and the final temperature was 320 ℃.The injector port temperature was set at 290 ℃,and the interface temperature was 300 ℃.The carrier gas was high purity helium (purity 99.999%) with a constant flow rate of 1 ml/min.The injection volume was 1 μl with splitless injection.The MS conditions were as follows:EI source,ion source temperature 230 ℃,four-pole temperature 150 ℃,electron bombardment energy 70 eV,multiply voltage 2112 V,selective ion monitoring mode,solvent delay 7 min.The characteristic ions of sufentanil and fentanyl were obtained in 8.20-8.40 min and 7.60-7.80 min,respectively,according to the characteristic ion curve of sufentanil and fentanyl.Results The standard curve of sufentanil had good linear relationship in the range of 0.02-10.00 ng/ml and the equation was Y =0.1625X + 0.0316,R2 =0.9987.The extraction recovery was more than 80%,intra-day and inter-day determinations were less than 8%,and the limit of detection was 0.02 ng/ml.Conclusion When modified GC-MS is applied to determine the concentrations of sufentanil in plasma,not only the determination is sensitive and accurate,but also the procedures are simplified,and it is more suitable for the pharmacological research of sufentanil.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2013年第12期1464-1467,共4页 Chinese Journal of Anesthesiology
关键词 气相色谱-质谱法 舒芬太尼 血药浓度 Gas chromatography-mass spectrometry Sufentanil Plasma concentration
  • 相关文献

参考文献9

  • 1Woestenborghs R, Michielsen L, Heykants J. Rapid and sensitive gas chromatographic method for the determination of alfentanil and sufentanil in biological samples. J Chromatogr, 1981,224( 1 ) : 122- 127.
  • 2Dufresne C, Favetta P, Paradis C, et al. Comparative study of li- quid-liquid extraction and solid-phase extraction methods for the separation of sufentanil from plasma before gas chromatographic-mass spectrometric analysis. Clin Chem,2001, 47(3): 600-602.
  • 3Martens-Lobenhoffer J. Very sensitive and specific determination of sufentani| in human serum applying liquid chromatography-two stage mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2002,769(2): 227-233.
  • 4Palleschi L, Lucentini L, Ferretti E, et al. Quantitative deter- ruination of sufentanil in human plasma by liquid ehromatography- tandem mass spectrometry. J Pharm Biomed Anal, 2003,32 (2) : 329-336.
  • 5Rossl SS, Dyck JB, Yaksh Tt,. Simultaneous extraction of sufentaniland midazolam from human plasma. Clin China Acta, 1996,244 ( 1 ) : 103-110.
  • 6Woestenborghs RJ, Timmerman PM, Cornelissen ML, et al. Assay methods for sufentanil in plasma. Radioinununoassay versus gas chromatography-mass spectrometry. Anesthesiology, 1994, 80 ( 3 ) : 666-670.
  • 7曾晓晖,石磊,赵树进,张兴安,谭建坤,刘礼胜.LC-MS/MS法测定人血浆中舒芬太尼的血药浓度[J].中国临床药学杂志,2010,19(2):93-96. 被引量:14
  • 8金旨陆.u阿片受体激动剂舒芬太尼的药理作用和应用.中国现代臆用药学,1999,16(1):1-5.
  • 9刘鲲鹏,廖旭,薛富善.舒芬太尼的药理学和临床应用[J].中国医药导刊,2005,7(6):454-457. 被引量:229

二级参考文献30

  • 1Movig KL, Langen MC, Egberts AC. Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatography [J]. J Pham Biomed Anal, 1999, 21(4): 845.
  • 2Schmidt R, Bremerich DH, Geisslinger G. High sensitive determination of sufentanil in human plasma of parturients and neonates following patient-controlled epidural analgesia ( PCEA ) [ J ]. J Chromatogr Analyt Technol Biomed Life Sci, 2006,836(1- 2): 98.
  • 3Pallesehi L, Lucentini L, Ferretti E, et al. Quantitative determination of sufentanil in human plasma by liquid chromatography-tandem mass spectrometry[J]. J Pham Biomed Anal,2003,32(2) : 329.
  • 4Martens-Lobenhoffer J. Very sensitive and specific determination of sufentanil in human serum applying liquid chromatography-two stage mass spectrrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2002,769(2): 227.
  • 5Howie MB, Smith DF, Reiley TE, et al. Postoperative course after sufentanil or fentanyl anesthesia for coronary artery surgery. J Cardiothorac Vasc Anesth, 1991:5:485-489.
  • 6Philbin DM, Rosow CE, Schneider RC, et al. Fentanyl and sufentanil anesthesia revisited: how much is enough?Anesthesiology, 1990:73:5-11.
  • 7Bailey PL, Streisand JB, East KA, et al. Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil. Anesth Analg, 1990:70:8-15.
  • 8Bowdle TA, Ward R J. Induction of anesthesia with small doses of sufentanil or fentanyl: dose versus EEG response,speed of onset and thiopental requirement.Anesthesiology,1989:70:26-30.
  • 9Sperry R J, Bailey PL, Reichman MV, et al. Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Anesthesiology, 1992:77:416-420.
  • 10Wehlstabl C, Mayer N, Richlhlg B, et al. Effects of sufentaml on hltracranial pressure in neurosurgical patients.Anesthesia, 1991:46:837-840.

共引文献241

同被引文献20

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部